AliveCor CEO Priya Abani argues that Apple has made a habit of taking intellectual property from smaller medical device firms in order to improve the functionalities its Apple Watch. She also believes that Apple has been able to avoid taking accountability for this by “bombarding” smaller companies with litigation it knows they won’t be able to afford — a claim that medical IP lawyers have backed up.
A federal jury has awarded $2.54 billion in royalties to Merck, ruling against Gilead in a monumental patent infringement case involving two blockbuster hepatitis C drugs. The kicker? The judge has the power to triple that figure.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Supreme Court heard oral arguments in Medtronic (MDT) vs. Boston Scientific (BSX) in a patent litigation lawsuit Tuesday. Chances are the Minnesota-based medical device company will win this one. Luckily for Boston Scientific, logic doesn’t always play into legal interpretation. In 1991, Boston Scientific made a licensing agreement with Medtronic for its CRT medical […]
When a startup gets ready for some M&A action (and if they’re in healthcare, getting to this point was probably hard-fought and hard-won), a patent troll could come knocking. While the Federal Trade Commission is finally looking into patent trolls’ effect on innovation, patent trolls still lurk, according to a blog in the Wall Street […]
Passed in September 2011, the final phases of the America Invents Act went into effect in March. Cyrus Morton, a partner at the Minneapolis office of Robins, Kaplan, Miller & Ciresi said this law represents the biggest change since the 1950s. “This bill spent eight years in Congress and finally got passed when this administration […]
When selecting a lawyer to defend your patent application, consider experience drafting and a prosecuting application, defending patents after they are issued as well as general business experience.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The biotech industry has moved swiftly to decry the Supreme Court’s Prometheus decision where the nine justices ruled unanimously in favor of Mayo Clinic that natural bodily responses to medical treatment are not patent eligible. In an interview with MedCity News, Kevin Noonan, a partner with intellectual property law firm McDonnell Boehnen Hulbert & Berghoff, said that the […]
Specialty pharmaceutical company BioDelivery Sciences International (NASDAQ:BDSI) can now claim patent victories against all three patent challenges levied by a rival in a long-running patent dispute. The U.S. Patent and Trademark Office has rejected all claims made by MonoSol Rx in the third MonoSol patent that the New Jersey company alleged BDSI had infringed. In […]
BioDelivery Sciences International (NASDAQ:BDSI) has a patent victory against a competitor who claims the North Carolina pharmaceutical company’s drug delivery platform infringes on its technology. The United States Patent and Trademark Office rejected all 191 claims made by New Jersey-based MonoSol Rx as unpatentable. The dispute centers on the technology that forms BDSI’s drug-delivery platform. […]
Migraine headache treatment Treximet, developed by pharmaceutical company Pozen (NASDAQ:POZN), has won a patent victory against generics companies looking to introduce their versions of the drug. A federal judge in Texas has ruled that two Treximet patents are valid and enforceable, and were infringed by Par Pharmaceutical (NYSE:PRX), Alphapharm and Dr. Reddy’s Laboratories (NYSE:RDY). A […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.